2x9f

From Proteopedia

Jump to: navigation, search


2x9f, resolution 1.75Å ()
Ligands: ,
Activity: Receptor protein-tyrosine kinase, with EC number 2.7.10.1
Related: 2bba, 2vwu, 2vx0, 2vwv, 2vwz, 2vwy, 2vww, 2vx1, 2vwx


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



Contents

EPHB4 KINASE DOMAIN INHIBITOR COMPLEX

Publication Abstract from PubMed

Starting from the initial bis-anilinopyrimidine 1, good potency against EphB4 was retained when benzodioxole at C-4 was replaced by an indazole. The key interactions of the indazole with the protein were characterised by crystallographic studies. Further optimisation led to compound 20, a potent inhibitor of the EphB4 and Src kinases with good pharmacokinetics in various preclinical species and high fraction unbound in plasma. Compound 20 may be used as a tool for evaluating the potential of EphB4 kinase inhibitors in vivo.

Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors., Bardelle C, Barlaam B, Brooks N, Coleman T, Cross D, Ducray R, Green I, Brempt CL, Olivier A, Read J, Bioorg Med Chem Lett. 2010 Sep 15. PMID:20850301

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

About this Structure

2x9f is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

See Also

Reference

  • Bardelle C, Barlaam B, Brooks N, Coleman T, Cross D, Ducray R, Green I, Brempt CL, Olivier A, Read J. Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors. Bioorg Med Chem Lett. 2010 Sep 15. PMID:20850301 doi:10.1016/j.bmcl.2010.08.100

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools